Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 9185  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  Article in PDF (317 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  Abstract
 ::  Materials and Me...
 ::  Results
 ::  Discussion
 ::  References
 ::  Article Tables

 Article Access Statistics
    Viewed6159    
    Printed263    
    Emailed12    
    PDF Downloaded233    
    Comments [Add]    
    Cited by others 19    

Recommend this journal


 


 
ORIGINAL ARTICLE
Year : 2010  |  Volume : 56  |  Issue : 1  |  Page : 12-16

Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors


1 Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore-560 029, India
2 Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore-560 029, India
3 Department of Biostatistics, National Institute of Mental Health and Neurosciences, Bangalore-560 029, India

Date of Submission08-Jul-2009
Date of Decision04-Aug-2009
Date of Acceptance24-Nov-2009
Date of Web Publication12-Apr-2010

Correspondence Address:
J N Panicker
Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore-560 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0022-3859.62425

Rights and Permissions


 :: Abstract 

Background: Outcome following Acute Disseminated Encephalomyelitis (ADEM) is variable and there are only limited studies from India. Aim: The study aims to evaluate the predictors of functional outcome in a cohort of patients with ADEM. Setting: Tertiary-care teaching hospital. Materials and Methods: Patients admitted with the diagnosis of ADEM from 1999 to 2004 have been included. Clinical features and radiological findings were evaluated. Functional outcome at discharge was scored using modified Rankin Scale and patients were followed up regularly. Statistical Analysis: Chi-Square test or Fisher's exact test, and Student's t test for comparison of categorical and continuous variables, respectively, and logistic regression for multivariate analysis. Results: Sixty-one patients were evaluated (mean age 22±15.9 years, 1-65). Fifty-two patients had preceding febrile illness or vaccination with mean 9.1±12.5 days interval to first neurological symptom. Non-specific febrile illnesses were the commonest trigger. Commonest findings were motor signs (n=41), impaired consciousness (n=33), bladder symptoms (n=21), ataxia (n=15), and seizures (n=14). Between adult (mean age 30.1±13.1 years, 13-65, n=38), and pediatric (mean age 6.2±2.8 years, 1-12, n=23) patients, language disturbances were more common in the latter (P=0.047). MR imaging (n=35) demonstrated lesions mostly in frontoparietal white matter (n=23) and thalamus (n=15). Nine patients expired. Patients with poor functional outcome at discharge more often had impaired consciousness (P=0.038) and seizures (P=0.06). At follow-up (n=25), deficits included motor signs (n=15) and bladder symptoms (n=5). Conclusions: ADEM has a wide range of neurological presentations and language disturbances are more common in pediatric patients. The presence of impaired consciousness, and possibly seizures, predict poor functional outcome at hospital discharge.


Keywords: Acute disseminated encephalomyelitis, impaired consciousness, modified rankin scale, outcome, prognosis, seizures


How to cite this article:
Panicker J N, Nagaraja D, Kovoor J, Subbakrishna D K. Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors. J Postgrad Med 2010;56:12-6

How to cite this URL:
Panicker J N, Nagaraja D, Kovoor J, Subbakrishna D K. Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors. J Postgrad Med [serial online] 2010 [cited 2019 Nov 17];56:12-6. Available from: http://www.jpgmonline.com/text.asp?2010/56/1/12/62425


Acute Disseminated Encephalomyelitis (ADEM) is a monophasic, inflammatory demyelinating disorder of the central nervous system (CNS). [1],[2] Although the exact pathogenesis is unknown, there is evidence to suggest that it represents an autoimmune phenomenon, usually triggered by infections or vaccinations. [1],[2],[3] The clinical presentation is characterized by polysymptomatic neurological involvement and imaging shows multifocal demyelinating lesions in the brain and spinal cord. Clinical spectrum of disease, cerebrospinal fluid (CSF) findings, radiological features and distinguishing features from the first presentation of multiple sclerosis (MS) have been studied extensively. [4],[5],[6],[7],[8],[9]

Earlier reports have documented considerable morbidity amongst survivors of ADEM. [3] Although the prognosis has significantly improved with the advent of various immunomodulatory treatments, [4],[8] studies that specifically evaluate predictors of functional outcome are few. [10] Therefore, we undertook this study to evaluate the clinical features and radiological findings that could predict functional outcome in a cohort of patients with ADEM from south India.


 :: Materials and Methods Top


This study was carried out from 1999 to 2004 at a tertiary-care teaching hospital in south India. The study had Institutional Review Board approval; consent was obtained from all patients. Patients were diagnosed to have ADEM if they fulfilled the following criteria: [4]

Clinical features: Presentation with an acute polysymptomatic neurological disease, without a previous history of unexplained neurological symptoms.

Imaging: Cranial/spinal imaging (CT or MRI) showing one or multiple lesions suggestive of demyelination.

Serology and lumbar puncture: Exclusion of CNS infections, vasculitis and other autoimmune disorders, as described below.

Patients presenting with a clinically isolated demyelinating syndrome (eg. optic neuritis or transverse myelitis) or with clinical features to suggest additional peripheral nervous system (PNS) involvement were excluded. Any patients with clinical or radiological evidence for dissemination in time and space suggesting MS were excluded as well. Age, gender, history of antecedent infections or immunizations and symptoms at presentation and during the course of illness were evaluated. Patients were assessed by a standard neurological examination. Level of consciousness was assessed using the Glasgow Coma Scale (GCS).

Relevant investigations were performed to exclude infective or inflammatory etiologies: complete blood count, erythrocyte sedimentation rate, rheumatoid factor, LE cell, antinuclear antibody vasculitis screen and serological testing for human immunodeficiency virus. Lumbar puncture was done in all patients and CSF analyzed for cells, protein and sugar levels, viral serology (ELISA for Japanese Encephalitis and Herpes Simplex Virus antibodies), bacterial and fungal culture and cytology.

Computed tomography (CT) and/or MRI (superconducting 1.5 Tesla scanner) were performed during the acute stage of illness. CT was done using a third generation scanner and contrast enhanced images were obtained. MRI T1-weighted, T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences were acquired in the axial, sagittal and coronal planes. When feasible, contrast enhanced images were obtained using gadopentetate dimeglumine (0.1 mmol/kg). CT and MR images were read independently by a radiologist (JMEK) and number of lesions, distribution, hemorrhage, midline shift and pattern of contrast enhancement were noted. Standard 30-minute interictal surface electroencephalogram (EEG) was recorded in patients with impaired consciousness or seizures.

Patients were treated with high-dose intravenous corticosteroids, either methyl prednisolone (10-20 mg/kg) or dexamethasone (1 mg/kg), daily for three to five days. Subsequently, prednisolone (1 mg/kg orally) was started and continued for four weeks. Plasma exchange, intravenous immunoglobulin (2 gm/kg divided over five days) or repeat high-dose intravenous methyl prednisolone were given for patients who continued to deteriorate. Acutely ill patients were monitored in the intensive care unit and were ventilated when indicated. Seizures were managed with intravenous phenytoin. Functional outcome at discharge was graded using the modified Rankin Scale (mRS). This is a seven point scale from 0 (no symptoms) to six (death) and patients' outcome was classified as good (mRS≤3) or poor (mRS>3) [11] according to the evaluation at the time of discharge.

Patients stabilized on medical management were transferred to a comprehensive rehabilitation program. They were regularly reviewed at the out-patient clinic at six weeks and thereafter every three to six months, depending upon their clinical condition for 12 months. At each visit, the neurological condition was reassessed through history and a formal neurological examination. Repeat brain imaging was arranged if there was suggestion of progression or recurrence of neurological deficits.

Statistical analysis was performed using SPSS for Windows version 16.0 (SPSS Inc. Chicago, IL, USA). Comparison of categorical and continuous variables was performed using chi-square test or Fisher's exact test, and Student's t test, respectively. Multivariate analysis was performed using logistic regression analysis. P value of <0.05 was considered significant.


 :: Results Top


A total of 61 patients, 34 men and 27 women, were included in the study. Age ranged from 1 to 65 years (mean age 22±15.9 years). Clinical features are listed in [Table 1]. Neurological deficits of adult (mean age 30.1±13.1 years, range 13-65 years, n=38), and pediatric (mean age 6.2±2.8 years, range 1-12, n=23) patients were compared [Table 1] and language disturbances were more common in the latter (P=0.047). In 37 patients, progression of neurological deficits occurred over several days, ranging from 1 to 30 days (mean 9.1±6.4 days). A clear infectious event or vaccination preceded the illness in 52 patients (85%) [Table 2]. The interval between the preceding event and the first onset of neurological symptoms ranged from 1 to 60 days (mean 9.1±12.5 days).

Cerebrospinal fluid was abnormal in 41 (67%) patients. CSF protein was elevated in 26 patients and pleocytosis was seen in 32 (lymphocyte predominant in 29 and neutrophil predominant in 3) [Table 1]. Laboratory investigations for inflammatory or infective etiologies were normal in all patients.

CT imaging was performed in 44 patients and demonstrated hypodense lesions in the frontoparietal white matter in 31 (71%), with contrast enhancement in 3 (10%). Hyperdense lesions suggesting hemorrhage were seen in two patients. MR imaging was performed in 35 patients and the distribution of lesions in the CNS are given in [Table 3]. Contrast was administered in nine patients and lesions demonstrated uniform (n=2) or open ring (n=1) enhancement.

EEG recording was performed in 21 patients and the commonest abnormality was diffuse theta range background slowing (n=10). Other abnormal recordings included focal spike and wave discharge (n=1), diffuse beta range background slowing (n=1) and diffuse nonresponsive alpha background activity (alpha coma) (n=1). EEG was normal in eight patients. Following intravenous high-dose corticosteroids [methyl prednisolone (n=53), dexamethasone (n=8)], 46 patients showed improvement in neurological deficits. Seven continued to worsen and were treated with intravenous immunoglobulin (n=2), second course of methyl prednisolone (n=2) or plasma exchange (n=1). Four patients required mechanical ventilation. Nine patients expired, all adults (P=0.01), and causes for death included sepsis (n=7), bronchopneumonia (n=3) and cardiovascular autonomic dysfunction (n=2).

Hospital stay ranged from 5 to 16 days (mean 11.4 days). At the time of discharge, 45 patients had residual neurological deficits. Commonest deficits were motor weakness (n=36), ataxia (n=15) and visual impairment (n=3). Eleven patients had bladder symptoms. Functional outcome at the time of discharge was assessed using the modified Rankin scale (mean scores included in [Table 1]) and 34 patients had good outcome (scores≤3) while 18 had poor outcome (scores 4 or 5). Patients with poor functional outcome at discharge more often had impaired consciousness (GCS<10) at admission (P=0.038) and seizures, though the latter association did not attain statistical significance (P=0.06) [Table 4]. No clinically significant results were derived by multivariate analysis.

Twenty-five patients (48%) came for review to the outpatient clinic. Follow-up ranged from one to 12 months (mean 3.4±2.9 months). None of the patients developed recurrence of neurological symptoms during this period. Persisting complaints included motor signs (n=15) and bladder symptoms (n=5). Sixteen patients (64%) had improved score on the modified Rankin scale.


 :: Discussion Top


In our series, 61 patients presented over six years with clinical and radiological features suggesting ADEM; 85% of patients had a preceding infection or vaccination, most commonly a nonspecific febrile illness which was presumably viral in etiology. The nature of the preceding event did not influence the clinical features or radiological findings. [7] Prevalence of ADEM following immunization was low in our study compared to previous studies from India [7] and exclusion of patients with PNS involvement is likely to have contributed to this under-representation. [3]

Most patients presented with impaired consciousness, multifocal motor deficits and cranial neuropathies. As seizures, meningism and headache were common, viral or bacterial meningoencephalitis was the immediate differential diagnosis and was excluded by CSF analysis. The pattern of neurological deficits did not differ significantly from those previously reported in the literature. [4],[5],[6],[7],[8] Inclusion of adult and pediatric patients allowed for comparison between the two groups and language disturbances occurred more often in the latter. Though language disturbances have been described previously, [4],[8],[12] they are considered rare in ADEM. Diaschisis has been suggested as a possible mechanism, whereby lesions affecting the white matter tracts anatomically connected to the cortical language centers may result in aphasia. [13] About 50-70% of patients experience full clinical and radiological recovery over weeks [7],[14] and follow-up in our patients suggested a similar pattern.

It was observed that mortality was higher amongst adults. This is similar to the findings of studies done previously that report mortality in adult patients to be 8-25% while in children to be less that 5%. [5],[6],[12] In spite of advances in the treatment of ADEM and care of seriously ill patients, morbidity continues to be high amongst survivors. It would therefore be pertinent to identify the subset of patients who are predicted to fare poorly. Our study demonstrates that patients with impaired consciousness are more likely to have a poor outcome at hospital discharge. The reasons for this may be multifactorial and could reflect more severe disease or increased risk for complications. [4],[6],[8] A similar observation has been made in a cohort of seriously ill patients being treated in an intensive care unit setting. [10]

The occurrence of seizures has also been show to be associated with poor outcome, [10] and this is due to increased risk for neurological and systemic complications. Previous series report an incidence of seizures ranging from 4% to 35%, and there appears to be no correlation with age group or imaging findings, [4],[5],[6], [8, 12, 15] although it has been shown to be higher in seriously ill patients. [10] Though 23% of our patients developed seizures, the association with poor outcome showed only a trend for statistical significance. The semiology was most often generalized tonic clonic seizures, which is in contrast to partial motor status epilepticus that has most often been reported in the literature. [8] Three patients developed status epilepticus, which was controlled by intravenous phenytoin. Similar to previous observations, [12] diffuse background slowing was the commonest abnormality recorded in EEG. Though seizure recurrence has been reported, [6],[12] this was not seen in any of our patients.

Other parameters found to predict poor outcome include extent of lesions in the white matter [7] and brainstem. [16] Patients with acute hemorrhagic leukoencephalitis are expected to have poor outcome. [17] However, limited number of patients with this condition restricted the analysis of this variable.

Neuroradiology is paramount in diagnosing ADEM. In contrast to the high sensitivity of MRI in detecting lesions, [18] CT imaging may miss small lesions especially when performed early in the illness [2] and findings are often nonspecific. [19],[20] MRI was abnormal while CT was normal in 7 patients who underwent both CT and MR imaging. Frontal and parietal white matter, thalamus and cerebellar white matter/peduncles were most commonly involved. Deep grey matter involvement is common in ADEM and is often bilateral and symmetric. [2],[4],[5],[6],[18] In our series, 48% demonstrated lesions in the thalamus and 23% in the basal ganglia. In spite of extensively distributed lesions, mass effect may be relatively small [20] and was seen in only six patients. None of the radiological parameters were shown to predict functional outcome.

The heterogeneous nature of the study cohort was a limitation to our study and restricted the evaluation of some variables. A comprehensive search for potential ADEM-triggering pathogens was not performed and hence the pattern of antecedent infections in our geographical region was not accurately reported. Imaging was performed during the acute stage of illness and hence MRI could not be done in all patients, either because of poor general condition or due to financial constraints. The possibility that some patients had the first presentation of MS rather than ADEM could not be excluded as oligoclonal bands were not analyzed and patient review was limited to only a few months. Long-term follow-up would allow for the evaluation of persisting subtle deficits, such as neuropsychological impairment, and their impact on school or work performance, and this is an obvious area for further research.

In conclusion, ADEM has a wide range of neurological presentations and language disturbances are more common in pediatric patients. In this cohort of patients, the presence of impaired consciousness and seizures were the only clinical features shown to predict poor functional outcome at hospital discharge.

 
 :: References Top

1.Tenembaum S, Chitnis T, Ness J, Hahn JS; International Pediatric MS Study Group Neurology. Acute disseminated encephalomyelitis. Neurology 2007;68:S23-36.   Back to cited text no. 1      
2.Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J 2003;79:11-7.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Swamy HS, Shankar SK, Chandra PS, Aroor SR, Krishna AS, Perumal VG. Neurological complications due to beta-propionolactone (BPL) inactivated antirabies vaccination: Clinical, electrophysiological and therapeutic aspects. J Neurol Sci 1984;63:111-28.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients. Neurology 2001;56:1313-8.  Back to cited text no. 4  [PUBMED]    
5.Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308-12.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-22.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]  
7.Murthy JM, Yangala R, Meena AK, Jaganmohan Reddy J. Acute disseminated encephalomyelitis: Clinical and MRI Study from South India. J Neurol Sci 1999;165:133-8.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]  
8.Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology 2002;59:1224-31.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]  
9.Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68:S7-12.  Back to cited text no. 9  [PUBMED]  [FULLTEXT]  
10.Sonneville R, Demeret S, Klein I, Bouadma L, Mourvillier B, Audibert J, et al. Acute disseminated encephalomyelitis in the intensive care unit: Clinical features and outcome of 20 adults. Intensive Care Med 2008;34:528-32.  Back to cited text no. 10  [PUBMED]  [FULLTEXT]  
11.Good DC. Outcome assessment in chronic neurological disease. In: Good DC, editor. Handbook of Neurorehabilitation. New York: Marcel Dekker; 1994.  Back to cited text no. 11      
12.Singhi PD, Ray M, Singhi S, Kumar Khandelwal N. Acute disseminated encephalomyelitis in North Indian children: Clinical profile and follow-up. J Child Neurol 2006;21:851-7.  Back to cited text no. 12  [PUBMED]  [FULLTEXT]  
13.Brinar VV, Poser CM, Basic S, Petelin Z. Sudden onset aphasic hemiplegia: An unusual manifestation of disseminated encephalomyelitis. Clin Neurol Neurosurg 2004;106:187-96.   Back to cited text no. 13  [PUBMED]  [FULLTEXT]  
14.Kimura S, Nezu A, Ohtsuki N, Kobayashi T, Osaka H, Uehara S. Serial magnetic resonance imaging in children with postinfectious encephalitis. Brain Dev 1996;18:461-5.  Back to cited text no. 14  [PUBMED]  [FULLTEXT]  
15.de Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, et al. Acute fulminant demyelinating disease: A descriptive study of 60 patients. Arch Neurol 2007;64:1426-32.  Back to cited text no. 15  [PUBMED]  [FULLTEXT]  
16.Donmez FY, Aslan H, Coskun M. Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging. Acta Radiol 2009;50:334-9.  Back to cited text no. 16  [PUBMED]  [FULLTEXT]  
17.Kuperan S, Ostrow P, Landi MK, Bakshi R. Acute hemorrhagic leukoencephalitis vs ADEM: Flair MRI and neuropathology findings. Neurology 2003;60:721-2.  Back to cited text no. 17  [PUBMED]  [FULLTEXT]  
18.Caldemeyer KS, Smith RR, Harris TM, Edwards MK. MRI in acute disseminated encephalomyelitis. Neuroradiology 1994;36:216-20.  Back to cited text no. 18  [PUBMED]    
19.Mader I, Stock KW, Ettlin T, Probst A. Acute disseminated encephalomyelitis: MR and CT features. AJNR Am J Neuroradiol 1996;17:104-9.  Back to cited text no. 19  [PUBMED]  [FULLTEXT]  
20.Sonneville R, Klein I, de Broucker T, Wolff M. Post-infectious encephalitis in adults: Diagnosis and management. J Infect 2009;58:321-8.  Back to cited text no. 20  [PUBMED]  [FULLTEXT]  



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]

This article has been cited by
1 Diagnosis and therapy of acute disseminated encephalomyelitis and its variants
Giulia Berzero,Andrea Cortese,Sabrina Ravaglia,Enrico Marchioni
Expert Review of Neurotherapeutics. 2016; 16(1): 83
[Pubmed] | [DOI]
2 Long term neurocognitive, psychosocial and MRI outcomes in pediatric onset Acute Disseminated Encephalomyelitis (ADEM)
Cynthia Beatty,Rachael A. Bowler,Osman Farooq,Lindsay Dudeck,Deepa Ramasamy,E. Ann Yeh,Robert Zivadinov,Bianca Weinstock-Guttman,Joy B. Parrish
Pediatric Neurology. 2016;
[Pubmed] | [DOI]
3 Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome
Diederik L. H. Koelman,Farrah J. Mateen
Journal of Neurology. 2015; 262(9): 2013
[Pubmed] | [DOI]
4 Lower urinary tract dysfunction in the neurological patient: clinical assessment and management
Jalesh N Panicker,Clare J Fowler,Thomas M Kessler
The Lancet Neurology. 2015; 14(7): 720
[Pubmed] | [DOI]
5 Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China: a retrospective study
Chang-hui Xiong,Yan Yan,Zhen Liao,Shi-hui Peng,Hai-rong Wen,Yan-xia Zhang,Shu-hua Chen,Jian Li,Hai-ying Chen,Xiao-wu Feng,Hui-qing Yao,Li Huang,Li Zhang
BMC Public Health. 2014; 14(1): 111
[Pubmed] | [DOI]
6 Refractory Fulminant Acute Disseminated Encephalomyelitis (ADEM) in an Adult
Federico Rodríguez-Porcel,Alejandro Hornik,Jordan Rosenblum,Ewa Borys,José Biller
Frontiers in Neurology. 2014; 5
[Pubmed] | [DOI]
7 The Magnetic Resonance Imaging Appearance of Monophasic Acute Disseminated Encephalomyelitis. An Update Post Application of the 2007 Consensus Criteria.
Marin, S.E. and Callen, D.J.A.
Neuroimaging Clinics of North America. 2013; 23(2): 245-266
[Pubmed]
8 Isolated and persistent cognitive dysfunction in a patient with acute disseminated encephalomyelitis
Adamec, I. and Klepac, N. and Kolenc, D. and Ozretić, D. and Habek, M.
Cognitive and Behavioral Neurology. 2013; 26(1): 30-35
[Pubmed]
9 Thalamic lesions profile by MRI as predictor of outcome in acute disseminated encephalomyelitis of childhood
Shoukry, I. and Yousry, M. and Ghaffar, H.M.A. and Farid, T. and Moharam, H.
Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2013; 50(1): 95-100
[Pubmed]
10 Isolated and Persistent Cognitive Dysfunction in a Patient with Acute Disseminated Encephalomyelitis
Ivan Adamec,Nataa Klepac,Danijela Kolenc,David Ozretic,Mario Habek
Cognitive And Behavioral Neurology. 2013; 26(1): 30
[Pubmed] | [DOI]
11 The Magnetic Resonance Imaging Appearance of Monophasic Acute Disseminated Encephalomyelitis
Samantha E. Marin,David J.A. Callen
Neuroimaging Clinics of North America. 2013; 23(2): 245
[Pubmed] | [DOI]
12 Immune Mediated Diseases and Immune Modulation in the Neurocritical Care Unit
Gloria Geldern,Thomas McPharlin,Kyra Becker
Neurotherapeutics. 2012; 9(1): 99
[Pubmed] | [DOI]
13 Biologically plausible and evidence-based risk intervals in immunization safety research
Ali Rowhani-Rahbar,Nicola P. Klein,Cornelia L. Dekker,Kathryn M. Edwards,Colin D. Marchant,Claudia Vellozzi,Bruce Fireman,James J. Sejvar,Neal A. Halsey,Roger Baxter
Vaccine. 2012; 31(1): 271
[Pubmed] | [DOI]
14 Treatment of Acute Disseminated Encephalomyelitis
Daniela Pohl,Silvia Tenembaum
Current Treatment Options in Neurology. 2012; 14(3): 264
[Pubmed] | [DOI]
15 Biologically plausible and evidence-based risk intervals in immunization safety research
Rowhani-Rahbar, A. and Klein, N.P. and Dekker, C.L. and Edwards, K.M. and Marchant, C.D. and Vellozzi, C. and Fireman, B. and Sejvar, J.J. and Halsey, N.A. and Baxter, R.
Vaccine. 2012; 31(1): 271-277
[Pubmed]
16 Treatment of acute disseminated encephalomyelitis
Pohl, D. and Tenembaum, S.
Current Treatment Options in Neurology. 2012; 14(3): 264-275
[Pubmed]
17 Immune Mediated Diseases and Immune Modulation in the Neurocritical Care Unit
von Geldern, G. and McPharlin, T. and Becker, K.
Neurotherapeutics. 2012; 9(1): 99-123
[Pubmed]
18 Acute disseminated encephalomyelitis
Coyle, P.K.
Current Clinical Neurology. 2011; 40: 203-217
[Pubmed]
19 Acute disseminated encephalomyelitis (ADEM) after pertussis infection
Budan, B., Ekici, B., Tatli, B., Somer, A.
Annals of Tropical Paediatrics. 2011; 31(3): 269-272
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow